|Place of Origin:||China|
|Model Number:||In - house|
|Minimum Order Quantity:||25kg|
|Payment Terms:||L/C, T/T|
|Supply Ability:||Ten tons per month|
|Product:||Raltegravir API||CAS NO.:||518048-05-0|
|Purity:||99.0%||Usage:||Anti Hepatitis C Virus|
CAS 518048-05-0 Active Pharmaceutical Ingredients Anti hepatitis C virus
CAS NO. 518048-05-0
Raltegravir is an antiretroviral drug produced by Merck & Co., used to treat HIV infection. It received approval by the U.S. Food and Drug Administration (FDA) on 12 October 2007, the first of a new class of HIV drugs, the integrase inhibitors, to receive such approval.
For the treatment of HIV-1 infection in conjunction with other antiretrovirals.
Mechanism of action :
Raltegravir targets integrase, an HIV enzyme that integrates the viral genetic material into human chromosomes, a critical step in the pathogenesis of HIV. The drug is metabolized away via glucuronidation.